10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2010 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Net revenues | $ 96,413 | 98,729 | 87,472 |
| Cost of revenues | 76,156 | 78,349 | 69,182 |
| Gross profit | 20,257 | 20,380 | 18,290 |
| Operating expenses | 14,092 | 13,942 | 12,244 |
| Operating profit | 6,165 | 6,438 | 6,046 |
| Interest expense, net | 536 | 525 | 509 |
| Income before income tax provision | 5,629 | 5,913 | 5,537 |
| Income tax provision | 2,190 | 2,205 | 2,193 |
| Income from continuing operations | 3,439 | 3,708 | 3,344 |
| Loss from discontinued operations, net of income tax benefit | (15) | (12) | (132) |
| Net income | 3,424 | 3,696 | 3,212 |
| Net loss attributable to noncontrolling interest | 3 | ||
| Preference dividends, net of income tax benefit | (14) | ||
| Net income attributable to CVS Caremark | 3,427 | 3,696 | 3,198 |
| Basic earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark | 2.52 | 2.59 | 2.32 |
| Loss from discontinued operations attributable to CVS Caremark | (0.01) | (0.01) | (0.09) |
| Net income attributable to CVS Caremark, basic | 2.51 | 2.58 | 2.23 |
| Weighted average common shares outstanding | 1,367 | 1,434 | 1,434 |
| Diluted earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark | 2.50 | 2.56 | 2.27 |
| Loss from discontinued operations attributable to CVS Caremark | (0.01) | (0.01) | (0.09) |
| Net income attributable to CVS Caremark, diluted | 2.49 | 2.55 | 2.18 |
| Weighted average common shares outstanding | 1,377 | 1,450 | 1,469 |
| Dividends declared per common share | 0.35 | 0.30 | 0.26 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2010 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Cash flows from operating activities: | |||
| Cash receipts from revenues | $ 94,503 | 93,568 | 82,250 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (73,143) | (73,536) | (64,131) |
| Cash paid to other suppliers and employees | (13,778) | (13,121) | (11,832) |
| Interest and dividends received | 4 | 5 | 20 |
| Interest paid | (583) | (542) | (574) |
| Income taxes paid | (2,224) | (2,339) | (1,786) |
| Net cash provided by operating activities | 4,779 | 4,035 | 3,947 |
| Cash flows from investing activities: | |||
| Additions to property and equipment | (2,005) | (2,548) | (2,180) |
| Proceeds from sale-leaseback transactions | 507 | 1,562 | 204 |
| Acquisitions (net of cash acquired) and other investments | (177) | (101) | (2,651) |
| Purchase of short-term investments | (5) | ||
| Proceeds from sale or maturity of short-term investments | 1 | 28 | |
| Proceeds from sale or disposal of assets | 34 | 23 | 19 |
| Net cash used in investing activities | (1,640) | (1,069) | (4,580) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (15) | (2,729) | 959 |
| Repayment of debt assumed in acquisition | (353) | ||
| Issuance of long-term debt | 991 | 2,800 | 350 |
| Repayments of long-term debt | (2,103) | (653) | (2) |
| Dividends paid | (479) | (439) | (383) |
| Derivative settlements | (5) | (3) | |
| Proceeds from exercise of stock options | 285 | 250 | 328 |
| Excess tax benefits from stock-based compensation | 28 | 19 | 53 |
| Repurchase of common stock | (1,500) | (2,477) | (23) |
| Net cash provided by (used in) financing activities | (2,798) | (3,232) | 929 |
| Net increase (decrease) in cash and cash equivalents | 341 | (266) | 296 |
| Cash and cash equivalents at beginning of year | 1,086 | 1,352 | |
| Cash and cash equivalents at end of year | 1,427 | 1,086 | 1,352 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,424 | 3,696 | 3,212 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,469 | 1,389 | 1,274 |
| Stock-based compensation | 150 | 165 | 92 |
| Deferred income taxes and other noncash items | 30 | 48 | (3) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | 532 | (86) | (291) |
| Inventories | (352) | (1,199) | (488) |
| Other current assets | (4) | 48 | 12 |
| Other assets | (210) | (2) | 19 |
| Accounts payable | (40) | 4 | (64) |
| Accrued expenses | (176) | (66) | 183 |
| Other long-term liabilities | (44) | 38 | 1 |
| Net cash provided by operating activities | 4,779 | 4,035 | 3,947 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2010 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2010 | Dec 31, 2009 | |
| Assets: | ||
| Cash and cash equivalents | $ 1,427 | 1,086 |
| Short-term investments | 4 | 5 |
| Accounts receivable, net | 4,925 | 5,457 |
| Inventories | 10,695 | 10,343 |
| Deferred income taxes | 511 | 506 |
| Other current assets | 144 | 140 |
| Total current assets | 17,706 | 17,537 |
| Property and equipment, net | 8,322 | 7,923 |
| Goodwill | 25,669 | 25,680 |
| Intangible assets, net | 9,784 | 10,127 |
| Other assets | 688 | 374 |
| Total assets | 62,169 | 61,641 |
| Liabilities: | ||
| Accounts payable | 4,026 | 3,560 |
| Claims and discounts payable | 2,569 | 3,075 |
| Accrued expenses | 3,070 | 3,246 |
| Short-term debt | 300 | 315 |
| Current portion of long-term debt | 1,105 | 2,104 |
| Total current liabilities | 11,070 | 12,300 |
| Long-term debt | 8,652 | 8,756 |
| Deferred income taxes | 3,655 | 3,678 |
| Other long-term liabilities | 1,058 | 1,102 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interest | 34 | 37 |
| Shareholders' equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | ||
| Common stock, par value $0.01: 3,200 shares authorized; 1,624 shares issued and 1,363 shares outstanding at December 31, 2010 and 1,612 shares issued and 1,391 shares outstanding at December 31, 2009 | 16 | 16 |
| Treasury stock, at cost: 259 shares at December 31, 2010 and 219 shares at December 31, 2009 | (9,030) | (7,610) |
| Shares held in trust: 2 shares at December 31, 2010 and 2009 | (56) | (56) |
| Capital surplus | 27,610 | 27,198 |
| Retained earnings | 19,303 | 16,355 |
| Accumulated other comprehensive loss | (143) | (135) |
| Total shareholders' equity | 37,700 | 35,768 |
| Total liabilities and shareholders' equity | 62,169 | 61,641 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |